Company Overview and News

 
DHFL stock cracks 42%; here#39;s what MD Kapil Wadhawan has to say about it

4h moneycontrol
Dewan Housing Finance Corporation (DHFL) share price plunged as much as 60 percent to hit fresh 52-week low of Rs 246.25 amid high volumes, but managed to trim a bit of losses on Friday.
GRUH 511072 IDKQY GRHFY 535322 CANFINHOME 532978 511196 SRTRANSFIN 511288 REPCOHOME 511218 535789 IBULHSGFIN DHFL BAJAJFINSV BAJFINANCE LICHSGFIN SRRQY BJJQY LHFLY 500253 500034

 
An evening walk down Dalal Street | A volatile end to the week, Sensex falls 279 pts; DHFL tanks 45%

5h moneycontrol
A largely volatile day has come to a close, with indices ending the day on a negative note. However, they are off the day’s low points. The Nifty has managed to give up 11,200 in today’s trade. The Sensex has closed over 200 points lower.
BHRYY 532617 511288 535789 534816 INFRATEL LHFLY 500253 GRAVITA SBAZ GRUH YESBANK KMBKY 511072 533282 IDKQY JETAIRWAYS GRHFY 532648 YYBKY IBULHSGFIN DHFL LICHSGFIN KOTAKBANK 500247

4
Sensex recovers 900 points after plummeting 1,100 points; Nifty reclaims 11,100

7h freepressjournal.in
Mumbai: The BSE Sensex recovered nearly 900 points after plummeting over 1,100 points within a matter of minutes in afternoon session on major selloff in finance stocks, despite firm global cues and rupee recovery. The 30-share index had plunged 1127.58 points, or 3.03 per cent, to hit an intra-day low of 35,993.64. It, however recovered nearly 900 points within minutes of the fall.
YESBANK 500469 IDKQY FDBAY 532648 CANFINHOME FEDA YYBKY 511196 535789 IBULHSGFIN LICHSGFIN FEDS LHFLY FEDERALBNK 500570 TATAMOTORS 500253 TTM

 
DHFL shares fall 50% on default rumour, drag housing finance stocks as well

8h livemint
Mumbai: Shares of housing finance companies came under sharp selling pressure on Friday after Dewan Housing Finance Ltd (DHFL) slumped over 50% in Friday’s afternoon trade, dragging down other home finance companies as well. Indiabulls Housing Finance Ltd slumped 23%, Gruh Finance 15%, LIC Housing Finance Ltd 15% and L&T Housing Finance Ltd 12%.
GRUH 535789 IBULHSGFIN DHFL 511072 LICHSGFIN IDKQY GRHFY LHFLY 500253 511288

 
DHFL stock cracks 60% to below Rs 300; here#39;s what MD Kapil Wadhawan has to say about it

8h moneycontrol
Dewan Housing Finance Corporation (DHFL) share price plunged as much as 60 percent to hit fresh 52-week low of Rs 246.25 amid high volumes on Friday.
GRUH 511072 IDKQY GRHFY 535322 CANFINHOME 532978 511196 SRTRANSFIN 511288 REPCOHOME 511218 535789 IBULHSGFIN DHFL BAJAJFINSV BAJFINANCE LICHSGFIN SRRQY BJJQY LHFLY 500253 500034

 
DHFL stock halves to trade below Rs 400, other housing finance firms also follow suit

9h moneycontrol
Dewan Housing Finance Corporation (DHFL) share price plunged 42.5 percent to hit fresh 52-week low of Rs 351.05 amid high volumes on Friday.
GRUH 511072 IDKQY GRHFY 535322 CANFINHOME 532978 511196 SRTRANSFIN 511288 REPCOHOME 511218 535789 IBULHSGFIN DHFL BAJAJFINSV BAJFINANCE LICHSGFIN SRRQY BJJQY LHFLY 500253 500034

 
LIC Housing Finance Limited - Updates

2018-09-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
LIC Housing Finance Limited - Updates

2018-09-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
LIC Housing Finance Limited - Updates

2018-09-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
LIC Housing Finance Limited - Updates

2018-09-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
LIC Housing Finance Limited - Updates

2018-09-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
LIC Housing Finance Limited - Updates

2018-09-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
10 stocks which moved the most last week; Shree Renuka Sugar, KIOCL top the charts

2018-09-15 moneycontrol
The market continued its recovery for the second consecutive session on Friday, with the Sensex rising more than 400 points intraday on short covering as well as value buying ahead of Prime Minister Narendra Modi's economy review meeting.
GRASIM GRSJY GRSXY LICHSGFIN 500300 LHFLY MS 500253

 
LIC Housing Finance Limited - Updates

2018-09-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

 
LIC Housing Finance Limited - Updates

2018-09-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
LICHSGFIN LHFLY 500253

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...